We are working on the following new projects:

• Smooth was awarded by 5 projects for medical writing and data management in CEE.

We are happy to reach the following milestones in our projects:

• All sites were closed in the III phase trial with Risperidone.
• All patients are enrolled in the Acetylcysteine trial in rhinosinusitis in March.
• All sites were opened in a III phase trial with Nimesulide.
• CSR was approved by the Sponsor in the Nadroparin trial.
• The site was opened in the Dutasteridum + Tamsulosinum bioequivalence study.

We successfully passed ISO certification by G-CERTI (S. Korea) for the following standards:

• ISO 9001:2015 "Quality Management Systems".
• ISO 27001:2013 "Information Security Management Systems".
• ISO 22301:2019 "Business Continuity Management Systems".